Evidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct.
about
Novel Association Between Immune-Mediated Susceptibility Loci and Persistent Autoantibody Positivity in Type 1 Diabetes.Evidence of gene-gene interaction and age-at-diagnosis effects in type 1 diabetes.Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseasesImmunoglobulin M gene association with autoantibody reactivity and type 1 diabetes.Genetic analysis of adult-onset autoimmune diabetesHLA-DR4-associated T and B cell responses to specific determinants on the IA-2 autoantigen in type 1 diabetes.Antigen targets of type 1 diabetes autoimmunityGenetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases.Shared Genetic Basis for Type 1 Diabetes, Islet Autoantibodies, and Autoantibodies Associated With Other Immune-Mediated Diseases in Families With Type 1 DiabetesHumoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes.Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes.HLA class II gene associations in African American type 1 diabetes reveal a protective HLA-DRB1*03 haplotype.Immune modulation in humans: implications for type 1 diabetes mellitus.Molecular mechanisms for contribution of MHC molecules to autoimmune diseasesImpact of disease heterogeneity on treatment efficacy of immunotherapy in Type 1 diabetes: different shades of gray.Humoral responses to islet antigen-2 and zinc transporter 8 are attenuated in patients carrying HLA-A*24 alleles at the onset of type 1 diabetes.Limited promiscuity of HLA-DRB1 presented peptides derived of blood coagulation factor VIII.Evaluation of Association Between HLA Class II DR4-DQ8 Haplotype and Type I Diabetes Mellitus in Children of East Azerbaijan State of Iran.Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients.Clinical and biochemical features at diagnosis of type 1 diabetes in patients between 0 and 18 years of age from Jordan.Attenuated humoral responses in HLA-A*24-positive individuals at risk of type 1 diabetes.Thyroid autoimmunity in relation to islet autoantibodies and HLA-DQ genotype in newly diagnosed type 1 diabetes in children and adolescents.Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study.
P2860
Q30300266-3E9F4B68-5003-48D6-9789-1C2A175A9FF4Q30416530-23EF378F-5D6D-4898-8F14-5C3C344699FBQ30419941-283C2693-14D1-45E3-8096-B229C6844E20Q33841459-93FEEB21-34CE-4F36-A14B-D7909CCB1A56Q35227229-8B582987-2A3F-4A2A-AEF5-B4F656575B30Q35851076-9240673A-F90E-4E1D-B0B4-428F9F713A2AQ35852999-AF6DA7A2-2325-48E5-8F78-4E92F9BD9A47Q36013572-A740C7A7-AE1A-416D-837A-7F92B185CBB6Q36092713-77A68B39-A8A8-4C00-9B91-BB85CDF5C928Q36330292-6FC2F30A-C2AC-4BFA-984A-FC08A8E0A44AQ36547660-4F9DF0B5-C631-4D22-A698-34E7DD35B6C6Q37005011-941DBD17-243B-4CE7-B476-DF5CFD1E4579Q38182297-9F4E2061-169D-4653-9441-1E678A52FF33Q38248679-C68EC91C-C738-489E-9281-583F51A8F7B9Q38365047-06D57F57-1DA7-496A-BD10-4E02F72A0645Q40944599-E61FFDD9-E1FA-4532-B668-C4D6F6BA017DQ42133506-5C9BDEDD-F9A4-4EA0-94A4-013FB9980F8AQ43179169-441EC328-1AB4-4AC6-9078-B9821FA6A058Q45342213-757FEA9F-9B1C-458A-9376-28310DDAB93BQ47245204-4D075582-57DB-48FF-ABA8-68BAD8BA0014Q50575182-52681242-9AF0-497C-B767-D8345AB40834Q51000479-AFADBC31-3FFE-488F-AF90-3C90314D15E0Q53647613-29F95B58-47E5-4611-A883-F3B38BFA6A66
P2860
Evidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Evidence that HLA class I and ...... ibodies to IA-2, are distinct.
@ast
Evidence that HLA class I and ...... ibodies to IA-2, are distinct.
@en
type
label
Evidence that HLA class I and ...... ibodies to IA-2, are distinct.
@ast
Evidence that HLA class I and ...... ibodies to IA-2, are distinct.
@en
prefLabel
Evidence that HLA class I and ...... ibodies to IA-2, are distinct.
@ast
Evidence that HLA class I and ...... ibodies to IA-2, are distinct.
@en
P2093
P2860
P50
P356
P1433
P1476
Evidence that HLA class I and ...... tibodies to IA-2, are distinct
@en
P2093
Helen Stevens
Kyla A Chandler
Polly J Bingley
P2860
P304
P356
10.2337/DB11-0131
P407
P577
2011-08-10T00:00:00Z